IP Library Granted Patent US 7,510,552
Granted Patent B2
US 7,510,552 · App. 11/203,532 · Granted Mar 31, 2009

Implantable medication delivery device using pressure regulator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,510,552
App. No.
11/203,532
Granted
Mar 31, 2009
Kind
B2
Abstract

An implantable medication delivery apparatus including a flow path coupling a medication reservoir to a device outlet port where the flow path includes a regulator means for limiting the magnitude of pressure transferred downstream from the medication reservoir. The regulator means is configured to respond to the reservoir pressure exceeding a certain threshold for closing a valve located downstream from the reservoir. The valve closure functions to isolate the device outlet port from further reservoir pressure increases which otherwise could induce unintended medication flow from the device outlet port.

Claims (33)

1. An implantable medication delivery device, comprising;

an implantable housing having a medication reservoir compartment, a fill port connected to the medication reservoir compartment, a sealed electronics compartment configured to maintain a substantially constant internal pressure therein, and an outlet port operably connected to the medication reservoir compartment;

at least one electronic device located within the sealed electronics compartment; and

a normally opened passive valve located within the implantable housing and including a valve element, movable between an open position that allows medication flow and a closed position that prevents medication flow, and a pressure responsive structure, operably connected to the valve element, having a first surface exposed to the substantially constant internal pressure of the sealed electronics compartment and a second surface exposed to medication flow within the implantable housing;

wherein the valve element and pressure responsive structure are respectively configured and positioned such that the valve element will move to the closed position when the pressure of the medication flow reaches a threshold pressure.

2. An implantable medication delivery device as claimed in claim 1 , wherein the threshold pressure is slightly less than the substantially constant internal pressure of the sealed electronics compartment.

3. An implantable medication delivery device as claimed in claim 1 , wherein the pressure responsive structure includes a bellows, defining a first end, a second end and an interior, and a plate that closes the first end of the bellows.

4. An implantable medication delivery device as claimed in claim 1 , wherein the normally opened passive valve is located between the medication reservoir compartment and the outlet port.

5. An implantable medication delivery device as claimed in claim 1 , further comprising:

a pump located between the normally opened passive valve and the outlet port.

6. An implantable medication delivery device as claimed in claim 1 , wherein the direction of medication flow through the passive valve is from the valve element to the pressure sensitive structure.

7. An implantable medication delivery device as claimed in claim 1 , wherein the at least one electronic device comprises electronic circuitry.

8. An implantable medication delivery device as claimed in claim 1 , further comprising:

a battery located within the sealed electronics compartment.

9. An implantable medication delivery device, comprising:

an implantable housing having a medication reservoir compartment, a fill port connected to the medication reservoir compartment, a sealed electronics compartment configured to maintain a substantially constant internal pressure therein, and an outlet port operably connected to the medication reservoir compartment; and

a normally opened passive valve located within the implantable housing and including

a tubular wall, defining a first end and a second end, and a valve seat adjacent to the first end of the tubular wall,

a valve element movable between an open position that allows medication flow and a closed position that prevents medication flow, and

a pressure responsive bellows that is located within the tubular wall, operably connected to the valve element, defines a first end, a second end secured to the second end of the tubular wall, and an interior exposed to the substantially constant internal pressure of the sealed electronics compartment, and has a plate exposed to medication flow within the implantable housing that closes the first end of the bellows;

wherein the valve element and bellows are respectively configured and positioned such that the valve element will move to the closed position when the pressure of the medication flow reaches a threshold pressure.

10. An implantable medication delivery device as claimed in claim 9 , wherein the tubular wall comprises a substantially cylindrical wall.

11. An implantable medication delivery device as claimed in claim 9 , wherein

the medication reservoir compartment and the sealed electronics compartment are separated by a partition; and

the first end of the tubular wall is secured to the partition.

12. An implantable medication delivery device as claimed in claim 11 , wherein

the implantable housing includes a cover;

the sealed electronics compartment is defined by the cover and the partition; and

the second end of the tubular wall is separated from the cover by a small gap.

13. An implantable medication delivery device as claimed in claim 9 , wherein

the valve element comprises a compliant disk that is configured to mate with the valve seat; and

the compliant disk is secured to the plate by a valve stem.

14. An implantable medication delivery device as claimed in claim 9 , wherein the tubular wall includes an aperture between the first and second ends.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057962/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: MEDALLION THERAPEUTICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 051287/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDALLION THERAPEUTICS, INC.
Reel/Frame 032892/0067 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE WHICH REFLECTED PATENT NUMBER AS 8,327,041 AND SHOULD HAVE BEEN REFLECTED AS 8,372,041. PREVIOUSLY RECORDED ON REEL 032815 FRAME 0188. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded May 6, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032827/0478 →
SECURITY INTEREST Recorded May 2, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032815/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2012
From: INFUSION SYSTEMS, LLC
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 028575/0931 →
CHANGE OF NAME Recorded Apr 14, 2008
From: ADVANCED BIONICS CORPORATION
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 020796/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2008
From: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
To: INFUSION SYSTEMS, LLC
Reel/Frame 020329/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2006
From: DAS, STEPHEN D.; LEBEL, RONALD J.
To: ADVANCED BIONICS CORPORATION
Reel/Frame 018378/0880 →